Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and Treatment

Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and Treatment

Aim. Description of risk factors, pathogenesis and treatment strategies of gastrointestinal bleeding (GIB) in the course of antithrombotic therapy in patients with coronary heart disease (CHD).Key points. Risk factors of GIB during antithrombotic therapy in CHD patients include: GIB, gastric and/or...

Full description

Bibliographic Details
Main Authors: N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, F. N. Muradova, L. Y. Koroleva
Format: Article
Language:Russian
Published: Gastro LLC 2020-07-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
gastrointestinal bleeding
coronary heart disease
acetylsalicylic acid
clopidogrel
dabigatran
rivaroxaban
apixaban
proton pump inhibitors
idarucizumab
Online Access:https://www.gastro-j.ru/jour/article/view/431

Internet

https://www.gastro-j.ru/jour/article/view/431

Similar Items